FDA
-
-
-
-
-
-
-
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
-
-
-
-
-
-
-
IMDX submits GraftAssureDx to FDA for transplant rejection testing
-
-
-
-
-
-
-
Insight Molecular Diagnostics Inc. (IMDX) PT Raised to $9 at Needham
-
-
-
-
-
-
-
Insight Molecular Diagnostics launches 5,000-patient registry study
-
-
-
-
-
-
-
iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025
-
-
-
326,433 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

